| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2002 | WO2001035951A3 Aryl nitrone therapeutics and methods for treating inflammatory bowel disease |
| 01/10/2002 | WO2001035946A3 Intranasal administration of raloxifene and tamoxifen |
| 01/10/2002 | WO2001035927A3 Topical application of muscarinic analgesic drugs such as neostigmine |
| 01/10/2002 | WO2001034633A3 Methods for treatment of human huntington's disease and methods of screening for active agents |
| 01/10/2002 | WO2001034604A3 Adenosine receptor antagonists and methods of making and using the same |
| 01/10/2002 | WO2001034603A3 Bicyclic and tricyclic heteroaromatic compounds |
| 01/10/2002 | WO2001034118A3 Solid dispersion pharmaceutical formulations |
| 01/10/2002 | WO2001032616A3 Oxetanone derivatives |
| 01/10/2002 | WO2001028594A3 Tumor detection by imaging and therapy of tumors |
| 01/10/2002 | WO2001028542A3 Combination therapy including camptothecin |
| 01/10/2002 | WO2001028535A3 Pharmaceutical formulations comprising a combination of s-salmeterol and fluticasone propionate |
| 01/10/2002 | WO2001028494A3 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 01/10/2002 | WO2001026641A3 Morpholinol derivatives for the treatment of obesity |
| 01/10/2002 | WO2001026639A3 Pharmaceutical composition of ateglinide and another antidiabeticagent |
| 01/10/2002 | WO2001021164A3 Anti-mycobacterium compositions and methods of preparing and using same |
| 01/10/2002 | WO2001000615A8 Respiratory syncytial virus replication inhibitors |
| 01/10/2002 | WO2001000196A3 Mirtazapine for weight gain in wasting diseases |
| 01/10/2002 | WO2000075347A3 Tet repressor-based transcriptional regulatory proteins |
| 01/10/2002 | WO2000069794A3 Use of calcium-activated potassium channel-modulating agents |
| 01/10/2002 | WO2000061138A8 Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
| 01/10/2002 | WO2000045800A3 Immunosurpressive effects of pteridine derivatives |
| 01/10/2002 | WO2000042864A3 Methods for reducing mortality rates in poultry |
| 01/10/2002 | US20020004679 Topoisomerase inhibitors for prevention of restenosis |
| 01/10/2002 | US20020004678 Surgical stent and method for preventing occlusion of stented vessels and conduits after implantation of stents |
| 01/10/2002 | US20020004608 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/10/2002 | US20020004604 Antidepressant; alkylation of chemical intermediate |
| 01/10/2002 | US20020004601 Cognition activators; antidepressants |
| 01/10/2002 | US20020004594 Phosphoramidates and methods therefor |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004531 Nitrone inhibition of cancer development |
| 01/10/2002 | US20020004530 Use of citrate-containing dialysate for renal dialysis treatment |
| 01/10/2002 | US20020004529 Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| 01/10/2002 | US20020004528 Method for the treatment of insomnia |
| 01/10/2002 | US20020004527 Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| 01/10/2002 | US20020004526 Medicament containing platinum complex compounds and the use thereof |
| 01/10/2002 | US20020004525 Reduce fluid pressure of nerve sheath using prostaglandins |
| 01/10/2002 | US20020004524 Administering 15-keto-prostaglandin |
| 01/10/2002 | US20020004523 Partially purified cocoa extracts containing cocoa polyphenols |
| 01/10/2002 | US20020004522 Nervous system disorders |
| 01/10/2002 | US20020004521 Use of HMG-COA reductase inhibitors to prevent and treat BPH |
| 01/10/2002 | US20020004520 Crystalline(-)-3r,4r-trans-7methoxy-2,2-dimethyl-3-phenyl-4-{4-[2- (pyrrolidin-1-yl)ethoxy]pheny 1}chromane, hydrogen malete |
| 01/10/2002 | US20020004519 Diarrhea therapy |
| 01/10/2002 | US20020004518 Pyrazolyl compound; anticoagulants, antiproliferative agent |
| 01/10/2002 | US20020004516 Use of riluzole in the treating acoustic traumas |
| 01/10/2002 | US20020004515 Treatment of diabetes with thiazolidinedione and metformin |
| 01/10/2002 | US20020004514 Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 01/10/2002 | US20020004513 Azacyclic compounds |
| 01/10/2002 | US20020004512 Sexual disorders |
| 01/10/2002 | US20020004510 Compounds for treating fibromyalgia and chronic fatigue syndrome |
| 01/10/2002 | US20020004509 Method of preventing abuse of opioid dosage forms |
| 01/10/2002 | US20020004508 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/10/2002 | US20020004506 In binder film |
| 01/10/2002 | US20020004505 Bactericides; anticancer agents |
| 01/10/2002 | US20020004504 Compound containing piperazine ring |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | US20020004502 Using taurolidine |
| 01/10/2002 | US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004500 Drug mixture for cardiovascular disorders |
| 01/10/2002 | US20020004499 Mixture of antibiotics; variations of releasing profiles |
| 01/10/2002 | US20020004498 Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 01/10/2002 | US20020004497 Combination injection preparation |
| 01/10/2002 | US20020004496 Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators |
| 01/10/2002 | US20020004495 Methods for stimulating bone formation |
| 01/10/2002 | US20020004494 Muscular disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004493 Interference with receptor binding; Alzheimer's disease |
| 01/10/2002 | US20020004488 Gene therapy |
| 01/10/2002 | US20020004486 Miticides, parasiticides; veterinary medicine |
| 01/10/2002 | US20020004484 Topical anesthetic/opioid formulations and uses thereof |
| 01/10/2002 | US20020004482 Treatment of acute lung injury and fibrosis with antagonists of avbeta6 |
| 01/10/2002 | US20020004477 Therapeutic administration of a modified alpha1 proteinase inhibitor |
| 01/10/2002 | US20020004239 Nucleotide sequences coding genetically engineered polypeptide; for use in the treatment of mammary gland cancer |
| 01/10/2002 | US20020004218 Bone disorders therapy |
| 01/10/2002 | US20020004208 Generating nicotine antibodies in situ |
| 01/10/2002 | US20020004078 Composition and method for treating the effects of diseases and maladies |
| 01/10/2002 | US20020004072 "composition providing a sustained release of l-histidine and methods of manufacture thereof" |
| 01/10/2002 | US20020004063 Methods and apparatus for drug delivery involving phase changing formulations |
| 01/10/2002 | US20020004056 Spirooxathiolane quinuclidine derivatives useful as drugs which promote the secretion of sebaceous and sweat glands through oral or parenteral administration |
| 01/10/2002 | US20020004054 Cosmetic compositions containing crosslinkable polymers |
| 01/10/2002 | US20020004049 Tryptophan source from plants and uses therfor |
| 01/10/2002 | US20020004046 Includes use of neutralizing antibody, high affinity antibodies, and viricide (ribavirin, amantadine, rimantadine, or a neuraminidase inhibitor); useful for controlling/treating respiratory syncytial virus in young children |
| 01/10/2002 | US20020004043 Cellular and animal models for diseases associated with altered mitochondrial function |
| 01/10/2002 | US20020004034 Use of sunscreen combinations comprising, as essential constituent, 4,4'-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical preparations |
| 01/10/2002 | US20020003179 Forming a dispersion of solid particles of a milled substrate in a fluid carrier comprising providing large size milling media and small size milling media, a conglomerate of solid comprising a substrate to be milled, milling, separating |
| 01/10/2002 | US20020002973 Increasing libido in humans via acute testosterone administration |
| 01/10/2002 | EP1143805A3 Method for reducing incidence of ascites in poultry by aid of natamycin |
| 01/10/2002 | DE10050527A1 Verwendung von Glukokortikosteroiden zur Herstellung eines Medikamentes für die Behandlung von Haarschwund The use of glucocorticosteroids for the preparation of a medicament for the treatment of hair loss |
| 01/10/2002 | DE10032165A1 Verwendung von physiologisch verträglichen Sulfinsäuren als Antioxidans oder Radikalfänger in kosmetischen oder dermatologischen Zubereitungen The use of physiologically compatible sulfinic acids as an antioxidant or free-radical scavengers in cosmetic or dermatological preparations |
| 01/10/2002 | DE10031971A1 Polymorphe Formen/Hydrate von N-[4-(3-Chlor-4-fluor-phenylamino)-7-(3-morpholin-4-yl-propoxy)-chinazolin-6-yl]-acrylamid Dihydrochlorid, Verfahren zu ihrer Herstellung sowie die Verwendung derselben zur Herstellung von Medikamenten mit irreversibler Tyrosinkinasehemmwirkung Polymorphic forms / hydrates of N- [4- (3-chloro-4-fluoro-phenylamino) -7- (3-morpholin-4-yl-propoxy) -quinazolin-6-yl] -acrylamide dihydrochloride, processes for their preparation and to the use thereof for the preparation of medicaments with irreversible Tyrosinkinasehemmwirkung |
| 01/10/2002 | DE10031585A1 2-Aminoalkyl-thieno[2,3-d]pyrimidine 2-aminoalkyl-thieno [2,3-d] pyrimidines |
| 01/10/2002 | DE10031584A1 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine 5-aminoalkyl-pyrazolo [4,3-d] pyrimidines |
| 01/10/2002 | DE10030345A1 Hochkonzentrierte stabile Meloxicamlösungen Highly concentrated stable meloxicam |
| 01/10/2002 | DE10029671A1 Biotransformation von biologisch aktiven Verindungen aus verschiedenen chemischen Stoffklassen mittels der Enzyme Laccase und Manganperoxidase Biotransformation of biologically active Verindungen from different classes of chemical substances by means of enzymes laccase and manganese peroxidase |
| 01/10/2002 | DE10019714A1 Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 01/10/2002 | CA2630062A1 Methods for treating graft versus host disease and immune disorders associated with rejection using a soluble ctla4 molecule |
| 01/10/2002 | CA2415037A1 Glucocortiocoid-selective antiinflammatory agents |
| 01/10/2002 | CA2414884A1 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | CA2414807A1 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | CA2414799A1 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | CA2414705A1 Thienopyrrolidinones |